Monash's most recent cohort of Fulbright, Rhodes and Schwarzman scholars share their passions and plans for the future.
Ebola bites back
Urgent action is needed to combat the second-biggest outbreak of the deadly virus that's claimed more than 1500 lives.
The ethics of experimental vaccines
Deliberately infecting people with a disease-causing agent as part of medical research can be ethically acceptable, and even necessary.
A guide to flu vaccines
The adjuvanted flu vaccine is free for over-65s and offers better protection than the standard vaccine. Here's what the research says.
For the greater good?
Sometimes, improving public health can mean infringing on people’s rights and compromising their interests.
New flu vaccines for the over-65s
Two free flu vaccines will improve protection for older people, but like those already available, they're not perfect.
Filling Victoria's manufacturing gap
Pharmacy and medical technology partnerships lead the transition.
Who determines priorities in funding medical research?
Is medical research is already adequately funded? AAPExpected cuts in health and medical research in the May Federal budget have led to a predicable backlash from vested interests. We are informed that any cuts will detrimentally affect standards of...
Professor of Infectious Diseases Epidemiology
Dean, Faculty of Pharmacy and Pharmaceutical Sciences
Professor, Monash Bioethics Centre
Associate Professor, Faculty of Pharmacy and Pharmaceutical Sciences
Professor of Sociology